SEC filingsOct 12, 2026 to Oct 19, 2026: insiders reported 840 purchases and sales across 212 companies.840 insider purchases and sales in 7 daysSee the filings →
HornScout

Company profile

SGMT

Sagimet Biosciences Inc.
NASDAQHealth Care

Latest close: 8.02 USD · Oct 16, 2026 · 1 year · split-adjusted

On the price, the facts of the public record■Insider buy□Insider sell●Results filed
With an account, also○dividends▲splits◌next earningswith an account

End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.

Latest on record

The most recent facts, as filed.

Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.

  1. Oct 1, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
  2. Sep 30, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
  3. Aug 14, 2026Reported sale · Form 4George Kemble · $3.6MOpen the filing ↗

In numbers

What this profile holds, counted.

Closes · 1 year250
SEC filings on record22715 flagged findings
Reported transactions (Form 4)80since Jan 29, 2024 · and 40 other holdings
Corporate events (8-K)18since Jul 27, 2023

What the record says

Description, identity and filings, each with its source.

Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.

SEC topics

Regulatory history

Topics detected in its SEC reports, with the original excerpt.

Each topic is assigned by a classifier over the full filing; the excerpts show where it was detected and are not always enough to verify it. Open the filing to read it in full.

  • 2026-05-12share offering or dilution eventrecentOpen filing ↗
    “…received aggregate net proceeds of 22 Table of Contents $190.9 million. Prior to becoming a public company, we raised $233.3 million…”
    +1 more passage from the same document
    • “…through public and private equity and debt financings, including our IPO of Series A common stock in July 2023 and our…”
  • 2026-04-28share offering or dilution eventrecentOpen filing ↗
    “…2023 Employee Stock Purchase Plan (ESPP); ​ • 1,000 shares of Series A common stock issuable upon exercise of an outstanding…”
    +1 more passage from the same document
    • “…$69.94 per share; and ​ • up to $75.0 million of shares of our Series A common stock remaining to be sold under the ATM Program. ​…”
  • 2026-04-28capital return (buybacks/dividends)recentOpen filing ↗
    “…or at the option of a holder of debt securities and the period or periods within which, the price or prices at which and in the…”
    +1 more passage from the same document
    • “…in the terms and conditions upon which securities of the series shall be redeemed or purchased, in whole or in part, pursuant to…”

Original excerpts from SEC filings, untranslated. Not advice and not a prediction.

SEC record

SEC dossier

What this company has filed with the SEC, in plain language.

The 25 most recent filings (of 227)

Everything filed

Every SEC filing, newest first, with what it is. Below, each type with its own explanation.

  • Oct 7, 26SCHEDULE 13G ↗Passive stake · Commodore Capital LP · 7.6% · event on Sep 30, 26
  • Oct 1, 268-K ↗Current report · Entered a material agreement
  • Oct 1, 26424B5 ↗Securities offering
  • Sep 30, 268-K ↗Current report · Communication to the market · Other events
  • Sep 30, 26424B3 ↗Securities offering
  • Aug 17, 26Form 4 ↗Insider transaction
  • Aug 14, 26Form 144 ↗Notice of proposed sale
  • Aug 14, 26SCHEDULE 13G ↗Passive stake · BALYASNY ASSET MANAGEMENT L.P. · 5.9% · event on Jun 30, 26
  • Aug 13, 268-K ↗Current report · Other events
  • Aug 12, 26Form 4 ↗Insider transaction
  • Aug 11, 26Form 144 ↗Notice of proposed sale
  • Aug 11, 268-K ↗Current report · Results · Communication to the market
  • Aug 11, 2610-Q ↗Quarterly report
  • Jul 30, 26SCHEDULE 13G ↗Passive stake · BlackRock, Inc. · 7.8% · event on Jun 30, 26
  • Insider transaction · 3 Form 4 filingsshow all 3hide
  • Jul 21, 268-K ↗Current report · Communication to the market
  • Jul 20, 26Form 144 ↗Notice of proposed sale
  • Insider transaction · 6 Form 4 filingsshow all 6hide

227 filings on record, the oldest from Apr 16, 21.

Listing the 25 most recent filings of the 227 on record.

8-Ks, explained

Structure5Governance13
  • Oct 1, 26StructureEntered a material agreement+1 more in the same filing8-K 1.01 ↗
  • Jun 12, 26GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
  • Jun 3, 26GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
  • Apr 28, 26StructureEntered a material agreement+1 more in the same filing8-K 1.01 ↗
  • Apr 21, 26GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
  • Aug 22, 25GovernanceAuditor change filing (8-K Item 4.01)+1 more in the same filing8-K 4.01 ↗
  • Aug 14, 25StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Jun 10, 25GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
  • Apr 30, 25GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Aug 16, 24StructureEntered a material agreement+1 more in the same filing8-K 1.01 ↗
  • Governance7 senior executive changes2023 – 2024show all 7hide
    • Aug 1, 24GovernanceA senior executive left or was appointed8-K 5.02 ↗
    • May 6, 24GovernanceA senior executive left or was appointed8-K 5.02 ↗
    • Mar 25, 24GovernanceA senior executive left or was appointed+3 more in the same filing8-K 5.02 ↗
    • Feb 2, 24GovernanceA senior executive left or was appointed8-K 5.02 ↗
    • Dec 29, 23GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
    • Nov 21, 23GovernanceA senior executive left or was appointed8-K 5.02 ↗
    • Jul 27, 23GovernanceA senior executive left or was appointed8-K 5.02 ↗

Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.

Ownership and control

Schedule 13G: short-form filing

The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.

  • BlackRock, Inc.7.8%Jun 30, 26SCHEDULE 13G ↗
  • Commodore Capital LP7.6%Sep 30, 26SCHEDULE 13G ↗4 co-filers on this document — the figure is the largest single stake, not their sum.
  • BALYASNY ASSET MANAGEMENT L.P.5.9%Jun 30, 26SCHEDULE 13G ↗5 co-filers on this document — the figure is the largest single stake, not their sum.
  • Point72 Asset Management, L.P.5.7%Mar 31, 25SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum.
  • AP11 Limited4.9%Jun 24, 25SCHEDULE 13G/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
show 2 more holdershide

Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.

Sale intention announced

On Aug 14, GEORGE KEMBLE filed notice of intent to sell up to $3.3M. That is about 0.57% of shares outstanding. It is filed under a scheduled plan (10b5-1), arranged in advance.

A notice is not a sale: it may not go ahead, may happen in part, or at a different price.

After the notice, they sold $3.6M on Aug 14, per their Form 4. That is 100% of the shares announced so far, and the window is still open.

View notice (Form 144) ↗+2 more recent notices · 2 with a later sale

SEC record

Insider transactions

Buys and sells reported by officers, directors and major shareholders on SEC Form 4.

Buys and sells

  • Aug 14, 26Sell$3.6MGeorge Kemble↗
  • Aug 11, 26Sell$201KGeorge Kemble↗
  • Jul 20, 26Sell$141KGeorge Kemble↗
  • Jul 20, 26Sell$82KElizabeth RozekChief Legal & Admin. Officer↗
  • Jul 20, 26Sell$497KDavid HappelPresident & CEO↗
  • Feb 10, 26Sell$14KElizabeth RozekChief Legal & Admin. Officer↗
  • Feb 10, 26Sell$20KEduardo Bruno MartinsChief Medical Officer↗
  • Feb 10, 26Sell$7KThierry ChaucheChief Financial Officer↗
  • Feb 10, 26Sell$65KDavid HappelPresident & CEO↗
  • Nov 20, 25Sell$290KGeorge KembleExecutive Chairman↗
  • Jul 21, 25Sell$98KElizabeth RozekGeneral Counsel and CCO↗
  • Jul 21, 25Sell$76KEduardo Bruno MartinsChief Medical Officer↗

There are 6 more transactions in this stretch.

Stock compensation, tax and giftsshow the 22 other transactionshide

Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.

  • Aug 14, 26Compensation$2.1MGeorge Kemble↗
  • Aug 14, 26Compensation$155KGeorge Kemble↗
  • Aug 11, 26Compensation$62KGeorge Kemble↗
  • Aug 11, 26Compensation$66KGeorge Kemble↗
  • Feb 19, 26Compensationamount n/aThierry ChaucheChief Financial Officer↗
  • Feb 19, 26Compensationamount n/aDavid HappelPresident & CEO↗
  • Feb 19, 26Compensationamount n/aEduardo Bruno MartinsChief Medical Officer↗
  • Feb 19, 26Compensationamount n/aElizabeth RozekChief Legal & Admin. Officer↗
  • Nov 4, 25Compensationamount n/aElizabeth RozekChief Legal & Admin. Officer↗
  • Feb 6, 25Compensationamount n/aThierry ChaucheChief Financial Officer↗
  • Feb 6, 25Compensationamount n/aElizabeth RozekGeneral Counsel and CCO↗
  • Feb 6, 25Compensationamount n/aDavid HappelPresident & CEO↗
  • Feb 6, 25Compensationamount n/aEduardo Bruno MartinsChief Medical Officer↗
  • Jan 29, 24Otheramount n/aNEW ENTERPRISE ASSOCIATES 13 LP↗
  • Jan 29, 24Otheramount n/aNEA Partners 13, Limited Partnership↗
  • Jan 29, 24Otheramount n/aNEA Partners 13, Limited Partnership↗
  • Jan 29, 24Otheramount n/aNEA Partners 13, Limited Partnership↗
  • Jan 29, 24Otheramount n/aFOREST BASKETT↗
  • Jan 29, 24Otheramount n/aFOREST BASKETT↗
  • Jan 29, 24Otheramount n/aFOREST BASKETT↗
  • Jan 29, 24Otheramount n/aFOREST BASKETT↗
  • Jan 29, 24Otheramount n/aPATRICK J KERINS↗

The full record holds 72 transactions and goes back to Jul 13, 23.

Its sector and its market

Sagimet Biosciences Inc. among Health Care companies

The profile shows what is on record. Context and Radar place the company among those of its sector and region.

With an account you also get

  • The four engines — growth, trend, risk and context — each with its word and its score.
  • The risk band and the sector phase.
  • The company's fundamentals and accounts.
  • Watchlist: your list of companies, with the «since you follow it» figure.

The research continues

The profile tells the story. The market sets the scene.

From Sagimet Biosciences Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.

  1. Place it in its market

    Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.

    See how Context works →
  2. See what deserves a closer look

    Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.

    See how Radar works →
  3. Keep the why

    Follow Sagimet Biosciences Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.

    See an example review →

Coverage

What sits behind this page.

Where each figure comes from and how far it reaches.

Prices
End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
Series quality
250 clean closes in the period.
SEC records
227 documents on file, from Apr 16, 2021 to Oct 7, 2026.
Company description
No description available.
This page
Generated on Oct 18, 2026; refreshed through the day.

Start at your own pace

Explore first. Go deeper with access.

Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.

Compare plans →
  • No account

    This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.

  • Pro

    What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.

  • Pro+

    Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.

Are the prices real time?

No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.

Which SEC documents appear here?

Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.

Why does a European company show no SEC records?

It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.

Before forming a view on a company,
read what is on record.

One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.

Access by invitation while the beta lasts. Not advice: the profile shows what is on record; it does not recommend.